77
Views
16
CrossRef citations to date
0
Altmetric
Original Research

lncRNA LEF1-AS1 Promotes Proliferation and Induces Apoptosis of Non-Small-Cell Lung Cancer Cells by Regulating miR-221/PTEN Signaling

, , , , &
Pages 3845-3850 | Published online: 25 May 2020

References

  • Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19.26667336
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • Goldstraw P, Ball D, Jett JR, et al. Non-small-cell lung cancer. Lancet. 2011;378(9804):1727–1740. doi:10.1016/S0140-6736(10)62101-021565398
  • Couraud S, Zalcman G, Milleron B, et al. Lung cancer in never smokers – a review. Eur J Cancer. 2012;48(9):1299–1311. doi:10.1016/j.ejca.2012.03.00722464348
  • Chen M, Liu X, Du J, et al. Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers. Oncotarget. 2017;8(1):133–144. doi:10.18632/oncotarget.1334627863400
  • Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi:10.1038/nature2518329364287
  • Kadara H, Scheet P, Wistuba II, et al. Early events in the molecular pathogenesis of lung cancer. Cancer Prev Res (Phila). 2016;9(7):518–527. doi:10.1158/1940-6207.CAPR-15-040027006378
  • Minna JD, Fong K, Zöchbauer-Müller S, et al. Molecular pathogenesis of lung cancer and potential translational applications. Cancer J. 2002;8:S41–S46.12075701
  • Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genom Proteom Bioinf. 2016;14(1):42–54. doi:10.1016/j.gpb.2015.09.006
  • Spizzo R, Almeida MI, Colombatti A, et al. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31(43):4577–4587. doi:10.1038/onc.2011.62122266873
  • Zhang C, Bao C, Zhang X, et al. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway. Cancer Biol Ther. 2019;20(9):1213–1222. doi:10.1080/15384047.2019.159967130983488
  • Wang J, Liu X, Yan C, et al. LEF1-AS1, a long-noncoding RNA, promotes malignancy in glioblastoma. Onco Targets Ther. 2017;10:4251–4260. doi:10.2147/OTT.S13036528894380
  • Wang A, Zhao C, Gao Y, et al. LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/FOXP1 axis in lung cancer. Invest New Drugs. 2019;37(6):1127–1134. doi:10.1007/s10637-018-00721-z30734202
  • Gong ZH, Zhou F, Shi C, et al. miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN. Cell Mol Biol Lett. 2019;24(1):9. doi:10.1186/s11658-018-0131-z30891072
  • Yin Z, Xu M, Li P. miRNA-221 acts as an oncogenic role by directly targeting TIMP2 in non-small-cell lung carcinoma. Gene. 2017;620:46–53. doi:10.1016/j.gene.2017.04.00728392366